FATE THERAPEUTICS INC Balance Sheet
FATE|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
FATE THERAPEUTICS INC had $319M in total assets and $319M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46.6M | $36.1M | $41.9M | $61.3M | $167.3M | $99.8M | $190.5M | $89.0M | $88.6M | $64.8M | $54.0M | $9.1M | $6.4M |
| Accounts Receivable | $916.0K | $3.5M | $1.8M | $38.5M | $8.7M | $5.5M | - | $500.0K | - | - | - | - | - |
| Current Assets | $208.7M | $291.9M | $331.5M | $502.1M | $633.4M | $494.3M | $227.1M | $205.2M | $102.6M | $93.3M | $65.7M | $49.9M | $54.7M |
| PP&E (Net) | $56.9M | $64.4M | $96.8M | $110.0M | $91.5M | $32.3M | $11.4M | $5.1M | $2.5M | $1.6M | $2.2M | $1.2M | $810.0K |
| Total Assets | $318.9M | $440.7M | $506.2M | $705.6M | $921.5M | $622.5M | $302.3M | $213.0M | $105.3M | $95.0M | $68.0M | $51.2M | $55.6M |
| Current Liabilities | $36.1M | $38.5M | $39.1M | $114.1M | $81.3M | $85.6M | $27.8M | $27.3M | $11.0M | $15.2M | $13.4M | $4.6M | $4.6M |
| Total Debt | - | - | - | - | - | - | - | $12.4M | $14.8M | $2.5M | $10.7M | $19.6M | $1.8M |
| Shareholders' Equity | $318.7M | $368.4M | $483.9M | $678.8M | $244.8M | $160.5M | $77.2M | $73.2M | $38.0M | $28.3M | $50.8M | -$52.8M | -$50.7M |